GENE ONLINE|News &
Opinion
Blog

Regulatory
Trials & Approvals Neurodegenerative Disease
Biogen’s BIIB059 May End a 10-Year Drought with New Lupus Drug
2019-12-18
Trials & Approvals Cancer
FoundationOne®CDx Approved as Companion Diagnostic for Novartis’ Piqray
2019-12-09
Trials & Approvals Cardiovascular Disease
Will Vascepa Receive a FDA Approval as a New Year Gift?
2019-12-02
Trials & Approvals RNAi
FDA approves second RNAi based drug
2019-11-20
Trials & Approvals Beta-thalassemia
Celgene, Acceleron’s novel anemia drug gets FDA green light for rare blood disorder
2019-11-11
R&D
Meru Reports Proof of Concept for Its Bispecific Antibody in NRG1 Fusion Cancers
2019-10-29
Trials & Approvals Asthma
Novartis Reports Trial Successes of its Asthma Drugs that Holds Potential Edge Over Longstanding Market Leader
2019-10-04
Licensing Immunotherapy Drug
FDA’s Advisory Committee Recommends Palforzia’s approval for Peanut Allergy Treatment
2019-09-27
Interviews
Crowdsourcing, a Novel Data Sharing Strategy to Augment Patient Care: Interview with Dr. Alireza Haghighi at Harvard Medical School
2019-09-10
Trials & Approvals Personalized Medicine
Rozlytrek Becomes the Third Tumor-Agnostic Medicine to be Approved by the USFDA
2019-08-21
Trials & Approvals ATM
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
Manufacturing ELARIS UF-I
AbbVie Files New Drug Application for its GnRH Antagonist
2019-08-13
Deals Gene Therapy
Sangamo’s Shares Goes up after the Announcement of Investigational Hemophilia A Gene Therapy Results
2019-07-19
Trials & Approvals Rare Disease
FDA Okays Expensive Gene Therapy for Infantile-Onset Spinal Muscular Atrophy
2019-05-29
Trials & Approvals CDK4/6
Kisqali Fulvestrant Combo Rejected by NICE for Breast Cancer Treatment in the UK
2019-05-02
1 … 49 50 51 52 53
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top